Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Devices & Dosimetry

Enhanced susceptibility of mouse squamous cell carcinoma to photodynamic therapy combined with low-dose administration of cisplatin

Administration of low-dose CDDP 3 hours before PDT appears to be a useful treatment modality.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors studied photodynamic therapy with Photofrin combined with low-dose cisplatin in mice with squamous cell carcinoma. They report that giving cisplatin 3 hours before therapy enhanced the antitumor effect, while giving it 1 hour before or immediately after did not. The authors conclude this timing appears to be a useful treatment approach.

Who or what was studied
NR-S1 mouse squamous cell carcinoma tumors in mice
Limits stated in the abstract
The abstract describes a mouse tumor model and does not report sample size or human data.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.

Record from PubMed, a service of the National Library of Medicine.

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Photodynamic therapy, Dose. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies